Sodium Bicarbonate NDC 55154-6754

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-6754Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-6754Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-6754-0	55154675400	10 BLISTER PACK in 1 BAG (55154-6754-0) / 1 TABLET in 1 BLISTER PACKMarketed from Jun 6, 2011

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Bicarbonate
Generic name (nonproprietary): sodium bicarbonate
Active ingredients: Sodium bicarbonate — 650 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cardinal Health 107, LLC
Product type: Over-the-counter drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 6, 2011
Marketing end: Oct 31, 2026
Other FDA classes: Alkalinizing Activity (Mechanism)
Identifiers: Product ID 55154-6754_73bf9e65-e5f5-4439-b4cf-a9e43214280eSPL ID 73bf9e65-e5f5-4439-b4cf-a9e43214280eSPL set ID f7c88834-aa7c-4aaa-ab9b-0cbcd1f4da3fRxCUI 198861UNII 8MDF5V39QOUPC 0055154675406

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154675400 followed by a unit qualifier and the quantity

Package 55154-6754-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 7, 2024.

Indications (excerpt from the label)

Indications and Usage Relieves - • acid indigestion • heartburn • sour stomach • upset stomach associated with these symptoms

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)